New Study Explores Contributors to Excess Infant Mortality in the U.S. South
reduce sudden unexpected infant death and prematurity can help close the gap
Efforts to reduce sudden unexpected infant death and prematurity can help close the gap
Ann Arbor, MI, February 4, 2014
consider infant mortality to be a key indicator of population health.
Currently, the United States ranks 27th among industrialized nations
in infant mortality, but rates within the U.S. vary significantly by race,
socioeconomic status, and geography. In particular, the Southern states suffer
from high rates of infant mortality, along with several other negative population
health indicators such as obesity and diabetes.
To better understand the contributing factors that lead to high rates of infant mortality in the South, researchers from the U.S. Department of Health and Human Services' Maternal and Child Health Bureau analyzed the most recent National Center for Health Statistics Period Linked Birth/Infant Death Data Files from 2007-2009. The goal of the research was to gain an understanding of the principal conditions and factors that contribute to excess infant mortality rates (IMRs) including race, underlying cause of death, and gestational age. Their findings are published in a new study in the March issue of the American Journal of Preventive Medicine.
Overall U.S. IMR for 2007-2009 was 6.59 per 1000 live births. After in-depth data analysis, investigators found that annually there were 1.18 excess infant deaths per 1000 live births in the South, which represents a total of about 1600 excess infant deaths per year, and 5018 excess infant deaths between 2007 and 2009.
"Overall, prematurity, congenital anomalies, and Sudden Unexpected Infant Death (SUID) were the three leading causes of death in the South and the rest of the U.S. However, SUID and preterm-related death were the largest causes of excess infant mortality in the South compared to other regions," says lead investigator Ashley H. Hirai, PhD.
Infant mortality rate (IMR) by state, 2007−2009
The study also found that
race played a pivotal role in the high IMRs found in the south, but that
various groups impacted states differently. "For example, the majority of
excess infant mortality was due to higher mortality rates among non-Hispanic
white infants in Kentucky and Oklahoma," explains Dr. Hirai. "Conversely, a
majority of excess infant mortality in Florida, Georgia, Mississippi, South
Carolina, and Louisiana could be explained by compositional differences due to
a larger proportion of non-Hispanic black births, which reflects a persistent
racial gap that exists across the country."
Investigators wanted to pinpoint the factors contributing to high IMRs in the South to help policy makers form successful reduction strategies. Promoting safe sleep practices in hospitals and communities, and preventing and treating chronic conditions before and between pregnancies are just some of the steps that can be taken to address the higher infant mortality rates in the U.S. South. The researchers highlighted the importance of state data systems to recognize needs and priorities among various risk and protective factors that can be targeted for intervention.
"To reduce excess Southern infant mortality, comprehensive strategies addressing SUID and preterm birth for both non-Hispanic black and white births are needed, with state-level findings used to tailor state-specific efforts," concludes Dr. Hirai. "These findings can be used to inform the prioritization of strategies within the new infant mortality Collaborative Improvement and Innovation Network (CoIIN) that originated in the South and through other public and private efforts to improve birth outcomes and reduce infant mortality at local and national levels."
# # #
Notes for editors
"Contributors to Excess Infant Mortality in the U.S. South," by Ashley H. Hirai, PhD; William M. Sappenfield, MD, MPH; Michael D. Kogan, PhD; Wanda D. Barfield, MD, MPH; David A. Goodman, PhD; Reem M. Ghandour, DrPH; Michael C. Lu, MD, MPH, is published in the American Journal of Preventive Medicine, Volume 46, Issue 3 (March 2014), DOI: http://dx.doi.org/10.1016/j.amepre.2013.12.006, published by Elsevier.
Full text of the article is available to credentialed journalists upon request; contact Angela J. Beck at +1 734 764 8775 or email@example.com. Journalists wishing to interview the authors should contact Samantha Miller, Office of Communications, U.S. Department of Health and Human Services, at +1 301 443 9094 or firstname.lastname@example.org.
About the American Journal of Preventive Medicine
The American Journal of Preventive Medicine (www.ajpmonline.org) is the official journal of The American College of Preventive Medicine (www.acpm.org) and the Association for Prevention Teaching and Research (http://www.aptrweb.org/). It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.
The American Journal of Preventive Medicine, with an Impact Factor of 3.945, is ranked 15th out of 158 Public, Environmental, and Occupational Health titles and 18th out of 151 General & Internal Medicine titles according to the 2012 Journal Citation Reports® published by Thomson Reuters.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Angela J. Beck, PhD, MPH
+1 734 764 8775